• Latest Posts
Interview 29 Nov 2022

LAG-3: The next big checkpoint inhibitor target

Interview 28 Nov 2022

Breaking barriers to gene therapies for childhood rare diseases

Interview 23 Nov 2022

What recent mixed clinical results can teach about Alzheimer’s disease

Interview 18 Nov 2022

How cardioids can usher in the next generation of drug discovery

Interview 14 Nov 2022

MaaT Pharma: leading the charge in microbiome therapeutics

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

Interview 7 Nov 2022

AI could tackle pharmaceutical manufacturing bottlenecks

Interview 31 Oct 2022

AI and biobanks could open the way to longevity treatments

Interview 28 Oct 2022

Migraines: a new vaccine frontier beyond infectious diseases

Interview 17 Oct 2022

CRISPR gene editing: a key tool for counteracting climate change

Interview 12 Oct 2022

Boosting pharma’s falling productivity with AI in drug discovery

Interview 28 Sep 2022

How the alternative protein space aims to address food waste